Preview

Drug development & registration

Advanced search
Fullscreen

For citations:


Gordeeva D.S., Nasibullin S.F., Karpov A.G., Khutoryanskiy V.V., Moustafine R.I. Eudragit® EPO, modified with 4-phenylboronic acid groups, as a novel polymeric excipient with enhanced mucoadhesive properties. Drug development & registration. 2024;13(3):93-102. (In Russ.) https://doi.org/10.33380/2305-2066-2024-13-3-1866

Views PDF (Rus): 120


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-2066 (Print)
ISSN 2658-5049 (Online)